Global Thin Film Drug

Thin Film Drug Comprehensive Study by Type (Transdermal Film, Oral Thin Film), Application (Hospitals, Clinics, Others), Indication Type (Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, Others), Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), Formation (Solvent Casting Method, Hot-Melt Extrusion, Semisolid Casting, Solid Dispersion Extrusion, Rolling) Players and Region - Global Market Outlook to 2028

Thin Film Drug Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Thin Film Drug Market Overview:
Thin-film drugs have proven to be an alternative to tablets or capsules because of their effective therapeutic results. The drugs are made of polymers that quickly dissolve when placed in the mouth or in the oral cavity and deliver the drug directly to the systemic circulation in the body. The thin film drugs have emerged as an alternative to tablets or capsules because of their efficient therapeutic results. The drugs are made up of polymers that quickly dissolve when placed in the mouth or in the oral cavity and deliver the drug directly to the systemic circulation in the body. The thin films are believed to be convenient to swallow, self-administer, and quickly dissolve, making them a versatile platform for drug delivery. There are various oral, buccal, sublingual, ocular, and transdermal routes of administration. In addition, the growing investment by pharmaceutical companies in research and development programs is fueling market growth.

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Increasing Demand for Effective Drug Delivery Systems and The Rising Demand for Efficient Drug Delivery Routes and Its Adequacy

Market Growth Drivers:
The Increasing Demand for an Effective Way of Drug Delivery, The Thin Film Drugs Have Surfaced As an Alternate to Tablets or Capsules Due To Its Efficient Therapeutic Results and The Lower Manufacturing Costs of Thin Film Drugs

Challenges:
The Various Substitute Drugs Available

Restraints:
The Drawbacks Associated With the Conventional Forms of Dosage

Opportunities:
Beneficial Government Initiatives and The Growing Investments in Research and Development Programs by the Pharmaceutical Companies

Competitive Landscape:
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are GSK (United Kingdom), LTS (United States), J&J (United States), Indivior PLC (United States), Pfizer (United States), Sanofi (France), Church & Dwight (United States), tesa Labtec GmbH (Germany), Tapemark (United States), Prestige Consumer Healthcare (United States), Sun Pharmaceutical Industries Ltd. (India), MonoSol (United States), BioDelivery Sciences International, Inc. (United States), Arx (United States), ZIM (Israel) and NAL Pharma (Hong Kong). Additionally, following companies can also be profiled that are part of our coverage like AdhexPharma (France), Aavishkar (India), IntelGenx Technologies Corporation (Canada) and APR (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Thin Film Drug market by 2028. Considering Market by Indication Type, the sub-segment i.e. Schizophrenia will boost the Thin Film Drug market. Considering Market by Distribution Channel, the sub-segment i.e. Online Pharmacies will boost the Thin Film Drug market. Considering Market by Formation, the sub-segment i.e. Solvent Casting Method will boost the Thin Film Drug market.

Oral dissolving film is a thin film with an area of 1-20 cm2 (depends on the dose and drug loading) containing the drug. Drugs can be loaded up to a single dose of 30 mg. Formulation considerations (plasticizers, etc.) have been reported as important factors affecting the mechanical properties of the films. In the US Food and Drug Administration (US FDA), if the product is bioequivalent to that of the existing oral product the drug, an Abbreviated New Drug Application (ANDA) route is followed. There are no clinical studies associated with these generic approval processes (section 505 (j) of the Food, Drug, and Cosmetic Act). However, developed oral film product may exhibit a different pharmacokinetic profile compared to the existing marketed product. The ODF is categorized as ‘new dosage form’ and section 505 (b) (2) approval process needs to be followed.

What Can be Explored with the Thin Film Drug Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Thin Film Drug Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Thin Film Drug
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Thin Film Drug market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Thin Film Drug market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Providers of Thin Film Drug, End-Users, Potential Investors, Regulatory Bodies, Market Research Firms and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Transdermal Film
  • Oral Thin Film
By Application
  • Hospitals
  • Clinics
  • Others
By Indication Type
  • Schizophrenia
  • Migraine
  • Opioid Dependence
  • Nausea & Vomiting
  • Others

By Distribution Channel
  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies

By Formation
  • Solvent Casting Method
  • Hot-Melt Extrusion
  • Semisolid Casting
  • Solid Dispersion Extrusion
  • Rolling

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Increasing Demand for an Effective Way of Drug Delivery
      • 3.2.2. The Thin Film Drugs Have Surfaced As an Alternate to Tablets or Capsules Due To Its Efficient Therapeutic Results
      • 3.2.3. The Lower Manufacturing Costs of Thin Film Drugs
    • 3.3. Market Challenges
      • 3.3.1. The Various Substitute Drugs Available
    • 3.4. Market Trends
      • 3.4.1. Increasing Demand for Effective Drug Delivery Systems
      • 3.4.2. The Rising Demand for Efficient Drug Delivery Routes and Its Adequacy
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Thin Film Drug, by Type, Application, Indication Type, Distribution Channel, Formation and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Thin Film Drug (Value)
      • 5.2.1. Global Thin Film Drug by: Type (Value)
        • 5.2.1.1. Transdermal Film
        • 5.2.1.2. Oral Thin Film
      • 5.2.2. Global Thin Film Drug by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Others
      • 5.2.3. Global Thin Film Drug by: Indication Type (Value)
        • 5.2.3.1. Schizophrenia
        • 5.2.3.2. Migraine
        • 5.2.3.3. Opioid Dependence
        • 5.2.3.4. Nausea & Vomiting
        • 5.2.3.5. Others
      • 5.2.4. Global Thin Film Drug by: Distribution Channel (Value)
        • 5.2.4.1. Online Pharmacies
        • 5.2.4.2. Retail Pharmacies
        • 5.2.4.3. Hospital Pharmacies
      • 5.2.5. Global Thin Film Drug by: Formation (Value)
        • 5.2.5.1. Solvent Casting Method
        • 5.2.5.2. Hot-Melt Extrusion
        • 5.2.5.3. Semisolid Casting
        • 5.2.5.4. Solid Dispersion Extrusion
        • 5.2.5.5. Rolling
      • 5.2.6. Global Thin Film Drug Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Thin Film Drug (Volume)
      • 5.3.1. Global Thin Film Drug by: Type (Volume)
        • 5.3.1.1. Transdermal Film
        • 5.3.1.2. Oral Thin Film
      • 5.3.2. Global Thin Film Drug by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Others
      • 5.3.3. Global Thin Film Drug by: Indication Type (Volume)
        • 5.3.3.1. Schizophrenia
        • 5.3.3.2. Migraine
        • 5.3.3.3. Opioid Dependence
        • 5.3.3.4. Nausea & Vomiting
        • 5.3.3.5. Others
      • 5.3.4. Global Thin Film Drug by: Distribution Channel (Volume)
        • 5.3.4.1. Online Pharmacies
        • 5.3.4.2. Retail Pharmacies
        • 5.3.4.3. Hospital Pharmacies
      • 5.3.5. Global Thin Film Drug by: Formation (Volume)
        • 5.3.5.1. Solvent Casting Method
        • 5.3.5.2. Hot-Melt Extrusion
        • 5.3.5.3. Semisolid Casting
        • 5.3.5.4. Solid Dispersion Extrusion
        • 5.3.5.5. Rolling
      • 5.3.6. Global Thin Film Drug Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Thin Film Drug (Price)
      • 5.4.1. Global Thin Film Drug by: Type (Price)
  • 6. Thin Film Drug: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GSK (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. LTS (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. J&J (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Indivior PLC (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pfizer (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sanofi (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Church & Dwight (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Tesa Labtec GmbH (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Tapemark (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Prestige Consumer Healthcare (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Sun Pharmaceutical Industries Ltd. (India)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. MonoSol (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. BioDelivery Sciences International, Inc. (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Arx (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. ZIM (Israel)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. NAL Pharma (Hong Kong)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
  • 7. Global Thin Film Drug Sale, by Type, Application, Indication Type, Distribution Channel, Formation and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Thin Film Drug (Value)
      • 7.2.1. Global Thin Film Drug by: Type (Value)
        • 7.2.1.1. Transdermal Film
        • 7.2.1.2. Oral Thin Film
      • 7.2.2. Global Thin Film Drug by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Others
      • 7.2.3. Global Thin Film Drug by: Indication Type (Value)
        • 7.2.3.1. Schizophrenia
        • 7.2.3.2. Migraine
        • 7.2.3.3. Opioid Dependence
        • 7.2.3.4. Nausea & Vomiting
        • 7.2.3.5. Others
      • 7.2.4. Global Thin Film Drug by: Distribution Channel (Value)
        • 7.2.4.1. Online Pharmacies
        • 7.2.4.2. Retail Pharmacies
        • 7.2.4.3. Hospital Pharmacies
      • 7.2.5. Global Thin Film Drug by: Formation (Value)
        • 7.2.5.1. Solvent Casting Method
        • 7.2.5.2. Hot-Melt Extrusion
        • 7.2.5.3. Semisolid Casting
        • 7.2.5.4. Solid Dispersion Extrusion
        • 7.2.5.5. Rolling
      • 7.2.6. Global Thin Film Drug Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Thin Film Drug (Volume)
      • 7.3.1. Global Thin Film Drug by: Type (Volume)
        • 7.3.1.1. Transdermal Film
        • 7.3.1.2. Oral Thin Film
      • 7.3.2. Global Thin Film Drug by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Others
      • 7.3.3. Global Thin Film Drug by: Indication Type (Volume)
        • 7.3.3.1. Schizophrenia
        • 7.3.3.2. Migraine
        • 7.3.3.3. Opioid Dependence
        • 7.3.3.4. Nausea & Vomiting
        • 7.3.3.5. Others
      • 7.3.4. Global Thin Film Drug by: Distribution Channel (Volume)
        • 7.3.4.1. Online Pharmacies
        • 7.3.4.2. Retail Pharmacies
        • 7.3.4.3. Hospital Pharmacies
      • 7.3.5. Global Thin Film Drug by: Formation (Volume)
        • 7.3.5.1. Solvent Casting Method
        • 7.3.5.2. Hot-Melt Extrusion
        • 7.3.5.3. Semisolid Casting
        • 7.3.5.4. Solid Dispersion Extrusion
        • 7.3.5.5. Rolling
      • 7.3.6. Global Thin Film Drug Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Thin Film Drug (Price)
      • 7.4.1. Global Thin Film Drug by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Thin Film Drug: by Type(USD Million)
  • Table 2. Thin Film Drug Transdermal Film , by Region USD Million (2017-2022)
  • Table 3. Thin Film Drug Oral Thin Film , by Region USD Million (2017-2022)
  • Table 4. Thin Film Drug: by Application(USD Million)
  • Table 5. Thin Film Drug Hospitals , by Region USD Million (2017-2022)
  • Table 6. Thin Film Drug Clinics , by Region USD Million (2017-2022)
  • Table 7. Thin Film Drug Others , by Region USD Million (2017-2022)
  • Table 8. Thin Film Drug: by Indication Type(USD Million)
  • Table 9. Thin Film Drug Schizophrenia , by Region USD Million (2017-2022)
  • Table 10. Thin Film Drug Migraine , by Region USD Million (2017-2022)
  • Table 11. Thin Film Drug Opioid Dependence , by Region USD Million (2017-2022)
  • Table 12. Thin Film Drug Nausea & Vomiting , by Region USD Million (2017-2022)
  • Table 13. Thin Film Drug Others , by Region USD Million (2017-2022)
  • Table 14. Thin Film Drug: by Distribution Channel(USD Million)
  • Table 15. Thin Film Drug Online Pharmacies , by Region USD Million (2017-2022)
  • Table 16. Thin Film Drug Retail Pharmacies , by Region USD Million (2017-2022)
  • Table 17. Thin Film Drug Hospital Pharmacies , by Region USD Million (2017-2022)
  • Table 18. Thin Film Drug: by Formation(USD Million)
  • Table 19. Thin Film Drug Solvent Casting Method , by Region USD Million (2017-2022)
  • Table 20. Thin Film Drug Hot-Melt Extrusion , by Region USD Million (2017-2022)
  • Table 21. Thin Film Drug Semisolid Casting , by Region USD Million (2017-2022)
  • Table 22. Thin Film Drug Solid Dispersion Extrusion , by Region USD Million (2017-2022)
  • Table 23. Thin Film Drug Rolling , by Region USD Million (2017-2022)
  • Table 24. South America Thin Film Drug, by Country USD Million (2017-2022)
  • Table 25. South America Thin Film Drug, by Type USD Million (2017-2022)
  • Table 26. South America Thin Film Drug, by Application USD Million (2017-2022)
  • Table 27. South America Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 28. South America Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 29. South America Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 30. Brazil Thin Film Drug, by Type USD Million (2017-2022)
  • Table 31. Brazil Thin Film Drug, by Application USD Million (2017-2022)
  • Table 32. Brazil Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 33. Brazil Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 34. Brazil Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 35. Argentina Thin Film Drug, by Type USD Million (2017-2022)
  • Table 36. Argentina Thin Film Drug, by Application USD Million (2017-2022)
  • Table 37. Argentina Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 38. Argentina Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 39. Argentina Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 40. Rest of South America Thin Film Drug, by Type USD Million (2017-2022)
  • Table 41. Rest of South America Thin Film Drug, by Application USD Million (2017-2022)
  • Table 42. Rest of South America Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 43. Rest of South America Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 44. Rest of South America Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 45. Asia Pacific Thin Film Drug, by Country USD Million (2017-2022)
  • Table 46. Asia Pacific Thin Film Drug, by Type USD Million (2017-2022)
  • Table 47. Asia Pacific Thin Film Drug, by Application USD Million (2017-2022)
  • Table 48. Asia Pacific Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 49. Asia Pacific Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 50. Asia Pacific Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 51. China Thin Film Drug, by Type USD Million (2017-2022)
  • Table 52. China Thin Film Drug, by Application USD Million (2017-2022)
  • Table 53. China Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 54. China Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 55. China Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 56. Japan Thin Film Drug, by Type USD Million (2017-2022)
  • Table 57. Japan Thin Film Drug, by Application USD Million (2017-2022)
  • Table 58. Japan Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 59. Japan Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 60. Japan Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 61. India Thin Film Drug, by Type USD Million (2017-2022)
  • Table 62. India Thin Film Drug, by Application USD Million (2017-2022)
  • Table 63. India Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 64. India Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 65. India Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 66. South Korea Thin Film Drug, by Type USD Million (2017-2022)
  • Table 67. South Korea Thin Film Drug, by Application USD Million (2017-2022)
  • Table 68. South Korea Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 69. South Korea Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 70. South Korea Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 71. Taiwan Thin Film Drug, by Type USD Million (2017-2022)
  • Table 72. Taiwan Thin Film Drug, by Application USD Million (2017-2022)
  • Table 73. Taiwan Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 74. Taiwan Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 75. Taiwan Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 76. Australia Thin Film Drug, by Type USD Million (2017-2022)
  • Table 77. Australia Thin Film Drug, by Application USD Million (2017-2022)
  • Table 78. Australia Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 79. Australia Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 80. Australia Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 81. Rest of Asia-Pacific Thin Film Drug, by Type USD Million (2017-2022)
  • Table 82. Rest of Asia-Pacific Thin Film Drug, by Application USD Million (2017-2022)
  • Table 83. Rest of Asia-Pacific Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 84. Rest of Asia-Pacific Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 85. Rest of Asia-Pacific Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 86. Europe Thin Film Drug, by Country USD Million (2017-2022)
  • Table 87. Europe Thin Film Drug, by Type USD Million (2017-2022)
  • Table 88. Europe Thin Film Drug, by Application USD Million (2017-2022)
  • Table 89. Europe Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 90. Europe Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 91. Europe Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 92. Germany Thin Film Drug, by Type USD Million (2017-2022)
  • Table 93. Germany Thin Film Drug, by Application USD Million (2017-2022)
  • Table 94. Germany Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 95. Germany Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 96. Germany Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 97. France Thin Film Drug, by Type USD Million (2017-2022)
  • Table 98. France Thin Film Drug, by Application USD Million (2017-2022)
  • Table 99. France Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 100. France Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 101. France Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 102. Italy Thin Film Drug, by Type USD Million (2017-2022)
  • Table 103. Italy Thin Film Drug, by Application USD Million (2017-2022)
  • Table 104. Italy Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 105. Italy Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 106. Italy Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 107. United Kingdom Thin Film Drug, by Type USD Million (2017-2022)
  • Table 108. United Kingdom Thin Film Drug, by Application USD Million (2017-2022)
  • Table 109. United Kingdom Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 110. United Kingdom Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 111. United Kingdom Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 112. Netherlands Thin Film Drug, by Type USD Million (2017-2022)
  • Table 113. Netherlands Thin Film Drug, by Application USD Million (2017-2022)
  • Table 114. Netherlands Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 115. Netherlands Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 116. Netherlands Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 117. Rest of Europe Thin Film Drug, by Type USD Million (2017-2022)
  • Table 118. Rest of Europe Thin Film Drug, by Application USD Million (2017-2022)
  • Table 119. Rest of Europe Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 120. Rest of Europe Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 121. Rest of Europe Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 122. MEA Thin Film Drug, by Country USD Million (2017-2022)
  • Table 123. MEA Thin Film Drug, by Type USD Million (2017-2022)
  • Table 124. MEA Thin Film Drug, by Application USD Million (2017-2022)
  • Table 125. MEA Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 126. MEA Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 127. MEA Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 128. Middle East Thin Film Drug, by Type USD Million (2017-2022)
  • Table 129. Middle East Thin Film Drug, by Application USD Million (2017-2022)
  • Table 130. Middle East Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 131. Middle East Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 132. Middle East Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 133. Africa Thin Film Drug, by Type USD Million (2017-2022)
  • Table 134. Africa Thin Film Drug, by Application USD Million (2017-2022)
  • Table 135. Africa Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 136. Africa Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 137. Africa Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 138. North America Thin Film Drug, by Country USD Million (2017-2022)
  • Table 139. North America Thin Film Drug, by Type USD Million (2017-2022)
  • Table 140. North America Thin Film Drug, by Application USD Million (2017-2022)
  • Table 141. North America Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 142. North America Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 143. North America Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 144. United States Thin Film Drug, by Type USD Million (2017-2022)
  • Table 145. United States Thin Film Drug, by Application USD Million (2017-2022)
  • Table 146. United States Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 147. United States Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 148. United States Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 149. Canada Thin Film Drug, by Type USD Million (2017-2022)
  • Table 150. Canada Thin Film Drug, by Application USD Million (2017-2022)
  • Table 151. Canada Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 152. Canada Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 153. Canada Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 154. Mexico Thin Film Drug, by Type USD Million (2017-2022)
  • Table 155. Mexico Thin Film Drug, by Application USD Million (2017-2022)
  • Table 156. Mexico Thin Film Drug, by Indication Type USD Million (2017-2022)
  • Table 157. Mexico Thin Film Drug, by Distribution Channel USD Million (2017-2022)
  • Table 158. Mexico Thin Film Drug, by Formation USD Million (2017-2022)
  • Table 159. Thin Film Drug Sales: by Type(K Tons)
  • Table 160. Thin Film Drug Sales Transdermal Film , by Region K Tons (2017-2022)
  • Table 161. Thin Film Drug Sales Oral Thin Film , by Region K Tons (2017-2022)
  • Table 162. Thin Film Drug Sales: by Application(K Tons)
  • Table 163. Thin Film Drug Sales Hospitals , by Region K Tons (2017-2022)
  • Table 164. Thin Film Drug Sales Clinics , by Region K Tons (2017-2022)
  • Table 165. Thin Film Drug Sales Others , by Region K Tons (2017-2022)
  • Table 166. Thin Film Drug Sales: by Indication Type(K Tons)
  • Table 167. Thin Film Drug Sales Schizophrenia , by Region K Tons (2017-2022)
  • Table 168. Thin Film Drug Sales Migraine , by Region K Tons (2017-2022)
  • Table 169. Thin Film Drug Sales Opioid Dependence , by Region K Tons (2017-2022)
  • Table 170. Thin Film Drug Sales Nausea & Vomiting , by Region K Tons (2017-2022)
  • Table 171. Thin Film Drug Sales Others , by Region K Tons (2017-2022)
  • Table 172. Thin Film Drug Sales: by Distribution Channel(K Tons)
  • Table 173. Thin Film Drug Sales Online Pharmacies , by Region K Tons (2017-2022)
  • Table 174. Thin Film Drug Sales Retail Pharmacies , by Region K Tons (2017-2022)
  • Table 175. Thin Film Drug Sales Hospital Pharmacies , by Region K Tons (2017-2022)
  • Table 176. Thin Film Drug Sales: by Formation(K Tons)
  • Table 177. Thin Film Drug Sales Solvent Casting Method , by Region K Tons (2017-2022)
  • Table 178. Thin Film Drug Sales Hot-Melt Extrusion , by Region K Tons (2017-2022)
  • Table 179. Thin Film Drug Sales Semisolid Casting , by Region K Tons (2017-2022)
  • Table 180. Thin Film Drug Sales Solid Dispersion Extrusion , by Region K Tons (2017-2022)
  • Table 181. Thin Film Drug Sales Rolling , by Region K Tons (2017-2022)
  • Table 182. South America Thin Film Drug Sales, by Country K Tons (2017-2022)
  • Table 183. South America Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 184. South America Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 185. South America Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 186. South America Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 187. South America Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 188. Brazil Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 189. Brazil Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 190. Brazil Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 191. Brazil Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 192. Brazil Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 193. Argentina Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 194. Argentina Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 195. Argentina Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 196. Argentina Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 197. Argentina Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 198. Rest of South America Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 199. Rest of South America Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 200. Rest of South America Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 201. Rest of South America Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 202. Rest of South America Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 203. Asia Pacific Thin Film Drug Sales, by Country K Tons (2017-2022)
  • Table 204. Asia Pacific Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 205. Asia Pacific Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 206. Asia Pacific Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 207. Asia Pacific Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 208. Asia Pacific Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 209. China Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 210. China Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 211. China Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 212. China Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 213. China Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 214. Japan Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 215. Japan Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 216. Japan Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 217. Japan Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 218. Japan Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 219. India Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 220. India Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 221. India Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 222. India Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 223. India Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 224. South Korea Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 225. South Korea Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 226. South Korea Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 227. South Korea Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 228. South Korea Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 229. Taiwan Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 230. Taiwan Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 231. Taiwan Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 232. Taiwan Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 233. Taiwan Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 234. Australia Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 235. Australia Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 236. Australia Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 237. Australia Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 238. Australia Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 239. Rest of Asia-Pacific Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 240. Rest of Asia-Pacific Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 241. Rest of Asia-Pacific Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 242. Rest of Asia-Pacific Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 243. Rest of Asia-Pacific Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 244. Europe Thin Film Drug Sales, by Country K Tons (2017-2022)
  • Table 245. Europe Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 246. Europe Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 247. Europe Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 248. Europe Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 249. Europe Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 250. Germany Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 251. Germany Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 252. Germany Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 253. Germany Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 254. Germany Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 255. France Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 256. France Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 257. France Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 258. France Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 259. France Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 260. Italy Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 261. Italy Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 262. Italy Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 263. Italy Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 264. Italy Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 265. United Kingdom Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 266. United Kingdom Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 267. United Kingdom Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 268. United Kingdom Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 269. United Kingdom Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 270. Netherlands Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 271. Netherlands Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 272. Netherlands Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 273. Netherlands Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 274. Netherlands Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 275. Rest of Europe Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 276. Rest of Europe Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 277. Rest of Europe Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 278. Rest of Europe Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 279. Rest of Europe Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 280. MEA Thin Film Drug Sales, by Country K Tons (2017-2022)
  • Table 281. MEA Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 282. MEA Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 283. MEA Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 284. MEA Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 285. MEA Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 286. Middle East Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 287. Middle East Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 288. Middle East Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 289. Middle East Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 290. Middle East Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 291. Africa Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 292. Africa Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 293. Africa Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 294. Africa Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 295. Africa Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 296. North America Thin Film Drug Sales, by Country K Tons (2017-2022)
  • Table 297. North America Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 298. North America Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 299. North America Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 300. North America Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 301. North America Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 302. United States Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 303. United States Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 304. United States Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 305. United States Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 306. United States Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 307. Canada Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 308. Canada Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 309. Canada Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 310. Canada Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 311. Canada Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 312. Mexico Thin Film Drug Sales, by Type K Tons (2017-2022)
  • Table 313. Mexico Thin Film Drug Sales, by Application K Tons (2017-2022)
  • Table 314. Mexico Thin Film Drug Sales, by Indication Type K Tons (2017-2022)
  • Table 315. Mexico Thin Film Drug Sales, by Distribution Channel K Tons (2017-2022)
  • Table 316. Mexico Thin Film Drug Sales, by Formation K Tons (2017-2022)
  • Table 317. Thin Film Drug: by Type(USD/Units)
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Company Basic Information, Sales Area and Its Competitors
  • Table 325. Company Basic Information, Sales Area and Its Competitors
  • Table 326. Company Basic Information, Sales Area and Its Competitors
  • Table 327. Company Basic Information, Sales Area and Its Competitors
  • Table 328. Company Basic Information, Sales Area and Its Competitors
  • Table 329. Company Basic Information, Sales Area and Its Competitors
  • Table 330. Company Basic Information, Sales Area and Its Competitors
  • Table 331. Company Basic Information, Sales Area and Its Competitors
  • Table 332. Company Basic Information, Sales Area and Its Competitors
  • Table 333. Company Basic Information, Sales Area and Its Competitors
  • Table 334. Thin Film Drug: by Type(USD Million)
  • Table 335. Thin Film Drug Transdermal Film , by Region USD Million (2023-2028)
  • Table 336. Thin Film Drug Oral Thin Film , by Region USD Million (2023-2028)
  • Table 337. Thin Film Drug: by Application(USD Million)
  • Table 338. Thin Film Drug Hospitals , by Region USD Million (2023-2028)
  • Table 339. Thin Film Drug Clinics , by Region USD Million (2023-2028)
  • Table 340. Thin Film Drug Others , by Region USD Million (2023-2028)
  • Table 341. Thin Film Drug: by Indication Type(USD Million)
  • Table 342. Thin Film Drug Schizophrenia , by Region USD Million (2023-2028)
  • Table 343. Thin Film Drug Migraine , by Region USD Million (2023-2028)
  • Table 344. Thin Film Drug Opioid Dependence , by Region USD Million (2023-2028)
  • Table 345. Thin Film Drug Nausea & Vomiting , by Region USD Million (2023-2028)
  • Table 346. Thin Film Drug Others , by Region USD Million (2023-2028)
  • Table 347. Thin Film Drug: by Distribution Channel(USD Million)
  • Table 348. Thin Film Drug Online Pharmacies , by Region USD Million (2023-2028)
  • Table 349. Thin Film Drug Retail Pharmacies , by Region USD Million (2023-2028)
  • Table 350. Thin Film Drug Hospital Pharmacies , by Region USD Million (2023-2028)
  • Table 351. Thin Film Drug: by Formation(USD Million)
  • Table 352. Thin Film Drug Solvent Casting Method , by Region USD Million (2023-2028)
  • Table 353. Thin Film Drug Hot-Melt Extrusion , by Region USD Million (2023-2028)
  • Table 354. Thin Film Drug Semisolid Casting , by Region USD Million (2023-2028)
  • Table 355. Thin Film Drug Solid Dispersion Extrusion , by Region USD Million (2023-2028)
  • Table 356. Thin Film Drug Rolling , by Region USD Million (2023-2028)
  • Table 357. South America Thin Film Drug, by Country USD Million (2023-2028)
  • Table 358. South America Thin Film Drug, by Type USD Million (2023-2028)
  • Table 359. South America Thin Film Drug, by Application USD Million (2023-2028)
  • Table 360. South America Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 361. South America Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 362. South America Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 363. Brazil Thin Film Drug, by Type USD Million (2023-2028)
  • Table 364. Brazil Thin Film Drug, by Application USD Million (2023-2028)
  • Table 365. Brazil Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 366. Brazil Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 367. Brazil Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 368. Argentina Thin Film Drug, by Type USD Million (2023-2028)
  • Table 369. Argentina Thin Film Drug, by Application USD Million (2023-2028)
  • Table 370. Argentina Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 371. Argentina Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 372. Argentina Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 373. Rest of South America Thin Film Drug, by Type USD Million (2023-2028)
  • Table 374. Rest of South America Thin Film Drug, by Application USD Million (2023-2028)
  • Table 375. Rest of South America Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 376. Rest of South America Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 377. Rest of South America Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 378. Asia Pacific Thin Film Drug, by Country USD Million (2023-2028)
  • Table 379. Asia Pacific Thin Film Drug, by Type USD Million (2023-2028)
  • Table 380. Asia Pacific Thin Film Drug, by Application USD Million (2023-2028)
  • Table 381. Asia Pacific Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 382. Asia Pacific Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 383. Asia Pacific Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 384. China Thin Film Drug, by Type USD Million (2023-2028)
  • Table 385. China Thin Film Drug, by Application USD Million (2023-2028)
  • Table 386. China Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 387. China Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 388. China Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 389. Japan Thin Film Drug, by Type USD Million (2023-2028)
  • Table 390. Japan Thin Film Drug, by Application USD Million (2023-2028)
  • Table 391. Japan Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 392. Japan Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 393. Japan Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 394. India Thin Film Drug, by Type USD Million (2023-2028)
  • Table 395. India Thin Film Drug, by Application USD Million (2023-2028)
  • Table 396. India Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 397. India Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 398. India Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 399. South Korea Thin Film Drug, by Type USD Million (2023-2028)
  • Table 400. South Korea Thin Film Drug, by Application USD Million (2023-2028)
  • Table 401. South Korea Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 402. South Korea Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 403. South Korea Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 404. Taiwan Thin Film Drug, by Type USD Million (2023-2028)
  • Table 405. Taiwan Thin Film Drug, by Application USD Million (2023-2028)
  • Table 406. Taiwan Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 407. Taiwan Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 408. Taiwan Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 409. Australia Thin Film Drug, by Type USD Million (2023-2028)
  • Table 410. Australia Thin Film Drug, by Application USD Million (2023-2028)
  • Table 411. Australia Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 412. Australia Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 413. Australia Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 414. Rest of Asia-Pacific Thin Film Drug, by Type USD Million (2023-2028)
  • Table 415. Rest of Asia-Pacific Thin Film Drug, by Application USD Million (2023-2028)
  • Table 416. Rest of Asia-Pacific Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 417. Rest of Asia-Pacific Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 418. Rest of Asia-Pacific Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 419. Europe Thin Film Drug, by Country USD Million (2023-2028)
  • Table 420. Europe Thin Film Drug, by Type USD Million (2023-2028)
  • Table 421. Europe Thin Film Drug, by Application USD Million (2023-2028)
  • Table 422. Europe Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 423. Europe Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 424. Europe Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 425. Germany Thin Film Drug, by Type USD Million (2023-2028)
  • Table 426. Germany Thin Film Drug, by Application USD Million (2023-2028)
  • Table 427. Germany Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 428. Germany Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 429. Germany Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 430. France Thin Film Drug, by Type USD Million (2023-2028)
  • Table 431. France Thin Film Drug, by Application USD Million (2023-2028)
  • Table 432. France Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 433. France Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 434. France Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 435. Italy Thin Film Drug, by Type USD Million (2023-2028)
  • Table 436. Italy Thin Film Drug, by Application USD Million (2023-2028)
  • Table 437. Italy Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 438. Italy Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 439. Italy Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 440. United Kingdom Thin Film Drug, by Type USD Million (2023-2028)
  • Table 441. United Kingdom Thin Film Drug, by Application USD Million (2023-2028)
  • Table 442. United Kingdom Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 443. United Kingdom Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 444. United Kingdom Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 445. Netherlands Thin Film Drug, by Type USD Million (2023-2028)
  • Table 446. Netherlands Thin Film Drug, by Application USD Million (2023-2028)
  • Table 447. Netherlands Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 448. Netherlands Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 449. Netherlands Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 450. Rest of Europe Thin Film Drug, by Type USD Million (2023-2028)
  • Table 451. Rest of Europe Thin Film Drug, by Application USD Million (2023-2028)
  • Table 452. Rest of Europe Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 453. Rest of Europe Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 454. Rest of Europe Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 455. MEA Thin Film Drug, by Country USD Million (2023-2028)
  • Table 456. MEA Thin Film Drug, by Type USD Million (2023-2028)
  • Table 457. MEA Thin Film Drug, by Application USD Million (2023-2028)
  • Table 458. MEA Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 459. MEA Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 460. MEA Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 461. Middle East Thin Film Drug, by Type USD Million (2023-2028)
  • Table 462. Middle East Thin Film Drug, by Application USD Million (2023-2028)
  • Table 463. Middle East Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 464. Middle East Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 465. Middle East Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 466. Africa Thin Film Drug, by Type USD Million (2023-2028)
  • Table 467. Africa Thin Film Drug, by Application USD Million (2023-2028)
  • Table 468. Africa Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 469. Africa Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 470. Africa Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 471. North America Thin Film Drug, by Country USD Million (2023-2028)
  • Table 472. North America Thin Film Drug, by Type USD Million (2023-2028)
  • Table 473. North America Thin Film Drug, by Application USD Million (2023-2028)
  • Table 474. North America Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 475. North America Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 476. North America Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 477. United States Thin Film Drug, by Type USD Million (2023-2028)
  • Table 478. United States Thin Film Drug, by Application USD Million (2023-2028)
  • Table 479. United States Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 480. United States Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 481. United States Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 482. Canada Thin Film Drug, by Type USD Million (2023-2028)
  • Table 483. Canada Thin Film Drug, by Application USD Million (2023-2028)
  • Table 484. Canada Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 485. Canada Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 486. Canada Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 487. Mexico Thin Film Drug, by Type USD Million (2023-2028)
  • Table 488. Mexico Thin Film Drug, by Application USD Million (2023-2028)
  • Table 489. Mexico Thin Film Drug, by Indication Type USD Million (2023-2028)
  • Table 490. Mexico Thin Film Drug, by Distribution Channel USD Million (2023-2028)
  • Table 491. Mexico Thin Film Drug, by Formation USD Million (2023-2028)
  • Table 492. Thin Film Drug Sales: by Type(K Tons)
  • Table 493. Thin Film Drug Sales Transdermal Film , by Region K Tons (2023-2028)
  • Table 494. Thin Film Drug Sales Oral Thin Film , by Region K Tons (2023-2028)
  • Table 495. Thin Film Drug Sales: by Application(K Tons)
  • Table 496. Thin Film Drug Sales Hospitals , by Region K Tons (2023-2028)
  • Table 497. Thin Film Drug Sales Clinics , by Region K Tons (2023-2028)
  • Table 498. Thin Film Drug Sales Others , by Region K Tons (2023-2028)
  • Table 499. Thin Film Drug Sales: by Indication Type(K Tons)
  • Table 500. Thin Film Drug Sales Schizophrenia , by Region K Tons (2023-2028)
  • Table 501. Thin Film Drug Sales Migraine , by Region K Tons (2023-2028)
  • Table 502. Thin Film Drug Sales Opioid Dependence , by Region K Tons (2023-2028)
  • Table 503. Thin Film Drug Sales Nausea & Vomiting , by Region K Tons (2023-2028)
  • Table 504. Thin Film Drug Sales Others , by Region K Tons (2023-2028)
  • Table 505. Thin Film Drug Sales: by Distribution Channel(K Tons)
  • Table 506. Thin Film Drug Sales Online Pharmacies , by Region K Tons (2023-2028)
  • Table 507. Thin Film Drug Sales Retail Pharmacies , by Region K Tons (2023-2028)
  • Table 508. Thin Film Drug Sales Hospital Pharmacies , by Region K Tons (2023-2028)
  • Table 509. Thin Film Drug Sales: by Formation(K Tons)
  • Table 510. Thin Film Drug Sales Solvent Casting Method , by Region K Tons (2023-2028)
  • Table 511. Thin Film Drug Sales Hot-Melt Extrusion , by Region K Tons (2023-2028)
  • Table 512. Thin Film Drug Sales Semisolid Casting , by Region K Tons (2023-2028)
  • Table 513. Thin Film Drug Sales Solid Dispersion Extrusion , by Region K Tons (2023-2028)
  • Table 514. Thin Film Drug Sales Rolling , by Region K Tons (2023-2028)
  • Table 515. South America Thin Film Drug Sales, by Country K Tons (2023-2028)
  • Table 516. South America Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 517. South America Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 518. South America Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 519. South America Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 520. South America Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 521. Brazil Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 522. Brazil Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 523. Brazil Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 524. Brazil Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 525. Brazil Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 526. Argentina Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 527. Argentina Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 528. Argentina Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 529. Argentina Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 530. Argentina Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 531. Rest of South America Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 532. Rest of South America Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 533. Rest of South America Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 534. Rest of South America Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 535. Rest of South America Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 536. Asia Pacific Thin Film Drug Sales, by Country K Tons (2023-2028)
  • Table 537. Asia Pacific Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 538. Asia Pacific Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 539. Asia Pacific Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 540. Asia Pacific Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 541. Asia Pacific Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 542. China Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 543. China Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 544. China Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 545. China Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 546. China Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 547. Japan Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 548. Japan Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 549. Japan Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 550. Japan Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 551. Japan Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 552. India Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 553. India Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 554. India Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 555. India Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 556. India Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 557. South Korea Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 558. South Korea Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 559. South Korea Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 560. South Korea Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 561. South Korea Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 562. Taiwan Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 563. Taiwan Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 564. Taiwan Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 565. Taiwan Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 566. Taiwan Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 567. Australia Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 568. Australia Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 569. Australia Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 570. Australia Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 571. Australia Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 572. Rest of Asia-Pacific Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 573. Rest of Asia-Pacific Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 574. Rest of Asia-Pacific Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 575. Rest of Asia-Pacific Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 576. Rest of Asia-Pacific Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 577. Europe Thin Film Drug Sales, by Country K Tons (2023-2028)
  • Table 578. Europe Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 579. Europe Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 580. Europe Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 581. Europe Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 582. Europe Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 583. Germany Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 584. Germany Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 585. Germany Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 586. Germany Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 587. Germany Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 588. France Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 589. France Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 590. France Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 591. France Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 592. France Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 593. Italy Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 594. Italy Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 595. Italy Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 596. Italy Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 597. Italy Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 598. United Kingdom Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 599. United Kingdom Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 600. United Kingdom Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 601. United Kingdom Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 602. United Kingdom Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 603. Netherlands Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 604. Netherlands Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 605. Netherlands Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 606. Netherlands Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 607. Netherlands Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 608. Rest of Europe Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 609. Rest of Europe Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 610. Rest of Europe Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 611. Rest of Europe Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 612. Rest of Europe Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 613. MEA Thin Film Drug Sales, by Country K Tons (2023-2028)
  • Table 614. MEA Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 615. MEA Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 616. MEA Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 617. MEA Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 618. MEA Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 619. Middle East Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 620. Middle East Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 621. Middle East Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 622. Middle East Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 623. Middle East Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 624. Africa Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 625. Africa Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 626. Africa Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 627. Africa Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 628. Africa Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 629. North America Thin Film Drug Sales, by Country K Tons (2023-2028)
  • Table 630. North America Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 631. North America Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 632. North America Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 633. North America Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 634. North America Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 635. United States Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 636. United States Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 637. United States Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 638. United States Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 639. United States Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 640. Canada Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 641. Canada Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 642. Canada Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 643. Canada Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 644. Canada Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 645. Mexico Thin Film Drug Sales, by Type K Tons (2023-2028)
  • Table 646. Mexico Thin Film Drug Sales, by Application K Tons (2023-2028)
  • Table 647. Mexico Thin Film Drug Sales, by Indication Type K Tons (2023-2028)
  • Table 648. Mexico Thin Film Drug Sales, by Distribution Channel K Tons (2023-2028)
  • Table 649. Mexico Thin Film Drug Sales, by Formation K Tons (2023-2028)
  • Table 650. Thin Film Drug: by Type(USD/Units)
  • Table 651. Research Programs/Design for This Report
  • Table 652. Key Data Information from Secondary Sources
  • Table 653. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Thin Film Drug: by Type USD Million (2017-2022)
  • Figure 5. Global Thin Film Drug: by Application USD Million (2017-2022)
  • Figure 6. Global Thin Film Drug: by Indication Type USD Million (2017-2022)
  • Figure 7. Global Thin Film Drug: by Distribution Channel USD Million (2017-2022)
  • Figure 8. Global Thin Film Drug: by Formation USD Million (2017-2022)
  • Figure 9. South America Thin Film Drug Share (%), by Country
  • Figure 10. Asia Pacific Thin Film Drug Share (%), by Country
  • Figure 11. Europe Thin Film Drug Share (%), by Country
  • Figure 12. MEA Thin Film Drug Share (%), by Country
  • Figure 13. North America Thin Film Drug Share (%), by Country
  • Figure 14. Global Thin Film Drug: by Type K Tons (2017-2022)
  • Figure 15. Global Thin Film Drug: by Application K Tons (2017-2022)
  • Figure 16. Global Thin Film Drug: by Indication Type K Tons (2017-2022)
  • Figure 17. Global Thin Film Drug: by Distribution Channel K Tons (2017-2022)
  • Figure 18. Global Thin Film Drug: by Formation K Tons (2017-2022)
  • Figure 19. South America Thin Film Drug Share (%), by Country
  • Figure 20. Asia Pacific Thin Film Drug Share (%), by Country
  • Figure 21. Europe Thin Film Drug Share (%), by Country
  • Figure 22. MEA Thin Film Drug Share (%), by Country
  • Figure 23. North America Thin Film Drug Share (%), by Country
  • Figure 24. Global Thin Film Drug: by Type USD/Units (2017-2022)
  • Figure 25. Global Thin Film Drug share by Players 2022 (%)
  • Figure 26. Global Thin Film Drug share by Players (Top 3) 2022(%)
  • Figure 27. Global Thin Film Drug share by Players (Top 5) 2022(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. GSK (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. GSK (United Kingdom) Revenue: by Geography 2022
  • Figure 31. LTS (United States) Revenue, Net Income and Gross profit
  • Figure 32. LTS (United States) Revenue: by Geography 2022
  • Figure 33. J&J (United States) Revenue, Net Income and Gross profit
  • Figure 34. J&J (United States) Revenue: by Geography 2022
  • Figure 35. Indivior PLC (United States) Revenue, Net Income and Gross profit
  • Figure 36. Indivior PLC (United States) Revenue: by Geography 2022
  • Figure 37. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 38. Pfizer (United States) Revenue: by Geography 2022
  • Figure 39. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 40. Sanofi (France) Revenue: by Geography 2022
  • Figure 41. Church & Dwight (United States) Revenue, Net Income and Gross profit
  • Figure 42. Church & Dwight (United States) Revenue: by Geography 2022
  • Figure 43. Tesa Labtec GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 44. Tesa Labtec GmbH (Germany) Revenue: by Geography 2022
  • Figure 45. Tapemark (United States) Revenue, Net Income and Gross profit
  • Figure 46. Tapemark (United States) Revenue: by Geography 2022
  • Figure 47. Prestige Consumer Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 48. Prestige Consumer Healthcare (United States) Revenue: by Geography 2022
  • Figure 49. Sun Pharmaceutical Industries Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 50. Sun Pharmaceutical Industries Ltd. (India) Revenue: by Geography 2022
  • Figure 51. MonoSol (United States) Revenue, Net Income and Gross profit
  • Figure 52. MonoSol (United States) Revenue: by Geography 2022
  • Figure 53. BioDelivery Sciences International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 54. BioDelivery Sciences International, Inc. (United States) Revenue: by Geography 2022
  • Figure 55. Arx (United States) Revenue, Net Income and Gross profit
  • Figure 56. Arx (United States) Revenue: by Geography 2022
  • Figure 57. ZIM (Israel) Revenue, Net Income and Gross profit
  • Figure 58. ZIM (Israel) Revenue: by Geography 2022
  • Figure 59. NAL Pharma (Hong Kong) Revenue, Net Income and Gross profit
  • Figure 60. NAL Pharma (Hong Kong) Revenue: by Geography 2022
  • Figure 61. Global Thin Film Drug: by Type USD Million (2023-2028)
  • Figure 62. Global Thin Film Drug: by Application USD Million (2023-2028)
  • Figure 63. Global Thin Film Drug: by Indication Type USD Million (2023-2028)
  • Figure 64. Global Thin Film Drug: by Distribution Channel USD Million (2023-2028)
  • Figure 65. Global Thin Film Drug: by Formation USD Million (2023-2028)
  • Figure 66. South America Thin Film Drug Share (%), by Country
  • Figure 67. Asia Pacific Thin Film Drug Share (%), by Country
  • Figure 68. Europe Thin Film Drug Share (%), by Country
  • Figure 69. MEA Thin Film Drug Share (%), by Country
  • Figure 70. North America Thin Film Drug Share (%), by Country
  • Figure 71. Global Thin Film Drug: by Type K Tons (2023-2028)
  • Figure 72. Global Thin Film Drug: by Application K Tons (2023-2028)
  • Figure 73. Global Thin Film Drug: by Indication Type K Tons (2023-2028)
  • Figure 74. Global Thin Film Drug: by Distribution Channel K Tons (2023-2028)
  • Figure 75. Global Thin Film Drug: by Formation K Tons (2023-2028)
  • Figure 76. South America Thin Film Drug Share (%), by Country
  • Figure 77. Asia Pacific Thin Film Drug Share (%), by Country
  • Figure 78. Europe Thin Film Drug Share (%), by Country
  • Figure 79. MEA Thin Film Drug Share (%), by Country
  • Figure 80. North America Thin Film Drug Share (%), by Country
  • Figure 81. Global Thin Film Drug: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • GSK (United Kingdom)
  • LTS (United States)
  • J&J (United States)
  • Indivior PLC (United States)
  • Pfizer (United States)
  • Sanofi (France)
  • Church & Dwight (United States)
  • tesa Labtec GmbH (Germany)
  • Tapemark (United States)
  • Prestige Consumer Healthcare (United States)
  • Sun Pharmaceutical Industries Ltd. (India)
  • MonoSol (United States)
  • BioDelivery Sciences International, Inc. (United States)
  • Arx (United States)
  • ZIM (Israel)
  • NAL Pharma (Hong Kong)
Additional players considered in the study are as follows:
AdhexPharma (France) , Aavishkar (India) , IntelGenx Technologies Corporation (Canada) , APR (United States)
Select User Access Type

Key Highlights of Report


Jul 2023 242 Pages 85 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Thin Film Drug Quantitative research analysis
Global Thin Film Drug Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Thin Film Drug market are GSK (United Kingdom), LTS (United States), J&J (United States), Indivior PLC (United States), Pfizer (United States), Sanofi (France), Church & Dwight (United States), tesa Labtec GmbH (Germany), Tapemark (United States), Prestige Consumer Healthcare (United States), Sun Pharmaceutical Industries Ltd. (India), MonoSol (United States), BioDelivery Sciences International, Inc. (United States), Arx (United States), ZIM (Israel) and NAL Pharma (Hong Kong), to name a few.
"Increasing Demand for Effective Drug Delivery Systems " is seen as one of major influencing trends for Thin Film Drug Market during projected period 2022-2028.
Transdermal Film segment in Global market to hold robust market share owing to "The Increasing Demand for an Effective Way of Drug Delivery ".

Know More About Global Thin Film Drug Report?

Have a Query? Click Here

Other Related Reports

Infusion Pharmacy Management Comprehensive Study by Type (Antibiotics, Antimicrobial, Pain Management, Enteral Nutrition, Others), Application (Hospital & Clinic, Ambulatory Surgical Centers, Home Ca...
$ 3350
Active Pharma Ingredient Comprehensive Study by Type (Innovative Active Pharmaceutical Ingredients, Generic Active Pharmaceutical Ingredients), Application (Oncology, Cardiovascular Disease, Diabetes...
$ 3750
Kinase Inhibitors Comprehensive Study by Type (Tyrosin Kinase Inhibitors (TKI), Receptor Tyrosine Kinase Inhibitors, Non-Receptor Tyrosine Kinase Inhibitors, Mulikinase Inhibitors, Threonine Kinase I...
$ 3750
Eye Care Products Comprehensive Study by Type (Artificial Tear Drops, Ointments or Emollients, Eye Washes, Hyperosomotics, Eyelid Scrubs, Decongestants, Antihistamines), Form (Cream, Solution, Other...
$ 3450
Calcitriol Comprehensive Study by Application (Osteoporosis, Renal Osteodystrophy, Others), Distribution Channel (Offline, Online), Form (Calcitriol Capsule, Calcitriol Solution), Disease Indication ...
$ 3450
Birth Control Pills Comprehensive Study by Type (Oral Contraceptives, Contraceptive Injectable), Application (Hospital Pharmacy, Independent Pharmacy, Online Platform, Clinics), Purchase Mode (Offlin...
$ 3500